New Hope for Pregnant Patients with Chronic Inflammatory Diseases The U.S. Food and Drug Administration (FDA) has recently granted Breakthrough Therapy Designation to Cimzia (certolizumab pegol). This significant regulatory milestone focuses on the treatment of pregnant women suffering from chronic inflammatory diseases, marking a potential shift in how these conditions are managed during pregnancy. What…